Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: October 8, 2026 at 9:37 PM UTC
| NCT Number | NCT07680790 |
| Recruiting Status | Recruiting |
| Condition | Non-Small Cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 850 participants |
| Active Locations | 35 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | October 8, 2026 (21 hours ago) |
As of October 8, 2026: Clinical trial NCT07680790 is currently recruiting participants. This phase3 study for non-small cell lung cancer is actively seeking new participants at 35 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07680790 is actively recruiting participants as of October 8, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 35 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07680790 was last updated 21 hours ago (October 8, 2026). HelloStudys verifies this status automatically.